Avadel Pharmaceuticals (AVDL) Tax Provisions: 2010-2020
Historic Tax Provisions for Avadel Pharmaceuticals (AVDL) over the last 11 years, with Dec 2020 value amounting to -$12.1 million.
- Avadel Pharmaceuticals' Tax Provisions rose 68.30% to -$2.9 million in Q4 2020 from the same period last year, while for Dec 2020 it was -$26.4 million, marking a year-over-year decrease of 392.89%. This contributed to the annual value of -$12.1 million for FY2020, which is 126.10% down from last year.
- Latest data reveals that Avadel Pharmaceuticals reported Tax Provisions of -$12.1 million as of FY2020, which was down 126.10% from -$5.4 million recorded in FY2019.
- In the past 5 years, Avadel Pharmaceuticals' Tax Provisions ranged from a high of $31.6 million in FY2016 and a low of -$17.9 million during FY2018.
- Its 3-year average for Tax Provisions is -$11.8 million, with a median of -$12.1 million in 2020.
- Its Tax Provisions has fluctuated over the past 5 years, first slumped by 173.37% in 2018, then spiked by 70.07% in 2019.
- Avadel Pharmaceuticals' Tax Provisions (Yearly) stood at $31.6 million in 2016, then dropped by 22.72% to $24.4 million in 2017, then plummeted by 173.37% to -$17.9 million in 2018, then skyrocketed by 70.07% to -$5.4 million in 2019, then crashed by 126.10% to -$12.1 million in 2020.